Sign In
Buy COLL
$31.06
+0.580 (+1.90%)
At Close: Jun 03, 2026
Collegium Pharmaceutical: No Longer Speculative After A Year Of Profitability
01:08pm, Thursday, 04'th Mar 2021
Despite the COVID -19 pandemic, Collegium Pharmaceutical had an impressive 2020. The company recorded a full year of profitability and commercial progress. Collegium is off to a good start in 2021, wi
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2020 Results - Earnings Call Transcript
04:53pm, Saturday, 27'th Feb 2021
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2020 Results - Earnings Call Transcript
Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update
04:01pm, Thursday, 11'th Feb 2021
STOUGHTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, Febru
Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday
06:31pm, Tuesday, 09'th Feb 2021
It's not every day that a company graduates to a slot in a high-profile stock index.
Collegium Provides 2021 Financial Guidance
04:01pm, Wednesday, 06'th Jan 2021
– Xtampza ® ER Revenues Expected in the Range of $155.0 million to $165.0 million –
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call Transcript
09:53am, Sunday, 08'th Nov 2020
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call Transcript
Investing $5,000 in These 2 Biotechs Could Make You Rich
07:05am, Sunday, 25'th Oct 2020
These two companies aren't reinventing the wheel, but they still have the potential for tremendous growth.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Could Be 32% Below Their Intrinsic Value Estimate
03:39pm, Friday, 07'th Aug 2020
Today we will run through one way of estimating the intrinsic value of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) by...
Collegium Pharmaceutical (COLL) Q2 Earnings Miss Estimates
11:15pm, Wednesday, 05'th Aug 2020
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -4.17% and 4.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020
08:01pm, Wednesday, 05'th Aug 2020
– Non-GAAP Net Income of $33.2 Million in the Second Quarter of 2020 – – Generated $43.9 Million in Cash from Operating Activities in the Second Quarter of 2020 –– Xtampza ® ER Net Revenue
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Collegium Pharmaceutical's Earnings: A Preview
04:04pm, Tuesday, 04'th Aug 2020
On Wednesday, August 05, Collegium Pharmaceutical (NASDAQ: COLL) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings an
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
04:59pm, Monday, 03'rd Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
04:33pm, Wednesday, 29'th Jul 2020
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
